(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Peripheral Neuropathy
Candidates 18 or older with type 1 or type 2 diabetes, with pain greater than four on a pain scale of 0-11 for seven consecutive days may be eligible for this study.
The research site is in Salisbury, N.C.
More information
Please see http://www.centerwatch.com/patient/studies/cat709.html.
-----
Urticaria
If your child is aged 1 to 5 with allergic rhinitis documented by a positive skin prick test or RAST performed within the last six months, and the child is a candidate for antihistamine treatment or has received an antihistamine in the past, the child may qualify for this study.
The research site is in El Paso, Texas.
More information
Please see http://www.centerwatch.com/patient/studies/cat811.html.
-----
Down Syndrome
Candidates with trisomy 21 down syndrome, mild-to-moderate cognitive dysfunction, aged 10 to 17, residing in the community with a caregiver, and having no unstable health conditions may be eligible for this study.
The research site is in Toledo, Ohio.
More information
Please see http://www.centerwatch.com/patient/studies/cat512.html.
-----
Copyright 2008 Thomson CenterWatch. All rights reserved.
2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.